title: Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days.
abstract: A pilot study was performed on the storage of plasma and cryosupernatant plasma at 4 degrees C for up to 28 days. Eight bags, four of CPD fresh-frozen plasma (FFP) and four of CPD cryosupernatant plasma (CSP, plasma without cryoprecipitate), were sampled during storage for assays of pH; factors V, VIII, IX, and XI; fibrinogen; prothrombin time; activated partial thromboplastin time (APTT); plasma protein electrophoresis; viscosity; and C1q binding. No changes were found in viscosity or the plasma protein electrophoretic pattern, and there was no detectable immune complex formation. The fibrinogen concentration remained constant, and the prothrombin time showed a gradual increase of 2.5 seconds for both groups of plasma. The labile coagulation factor V decreased gradually for FFP and CSP to 58 and 64 percent of its initial value, respectively (51 +/- 8% and 54 +/- 6% of the value of fresh pooled plasma). Factor VIII decreased to 36 percent of its initial value in FFP (48 +/- 14% of fresh pooled plasma). In CSP, factor VIII decreased after 28 days to 7 percent of its initial value (7 +/- 1% of fresh pooled plasma). The APTT increased for FFP from 28 to 35.8 +/- 1.1 seconds and for CSP from 36 to 49.5 +/- 4.9 seconds. The only chemical change observed for both plasmas was a rise in pH, from 7.27 to 7.56, after 28 days. The results of this pilot study indicate that FFP can be stored at 4 degrees C for 28 days with sufficient recovery of coagulation factors to maintain hemostasis.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Red Cross Blood Bank, Leiden, The Netherlands.
authors.forename: P J
authors.initials: PJ
authors.lastname: Smak Gregoor
authors.forename: M S
authors.initials: MS
authors.lastname: Harvey
authors.forename: E
authors.initials: E
authors.lastname: Briët
authors.forename: A
authors.initials: A
authors.lastname: Brand
mesh_terms: D001779:Blood Coagulation Factors / Q000032:analysis*; D001793:Blood Preservation; D015925:Cryopreservation; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005169:Factor VIII / Q000032:analysis*; D005172:Factor XI / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010314:Partial Thromboplastin Time; D010865:Pilot Projects; D010949:Plasma / Q000737:chemistry*; D011517:Prothrombin Time; D013997:Time Factors
chemical_list: D001779:Blood Coagulation Factors; C026912:cryoprecipitate coagulum; D005165:Factor V; D005169:Factor VIII; D005164:Factor IX; D005340:Fibrinogen; D005172:Factor XI